| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| fenofibrate | Tablet, film coated | 145 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 28/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| neostigmine methylsulfate | Injection, solution | 2.5 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| simvastatin | Tablet, film coated | 80 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| linezolid | Tablet, film coated | 600 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Manufacturing | 28/03/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 28/03/2025 |
| sodium nitroprusside | Injection, concentrated | 50 mg | Anticipated | Available | Commercial Changes / Commercial viability | 28/03/2025 |
| fentanyl citrate~ropivacaine hydrochloride | Injection, solution | 3.14 microgram/mL~2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 28/03/2025 |
| fentanyl citrate~ropivacaine hydrochloride | Injection, solution | 3.14 microgram/mL~2 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/03/2025 |
| ropivacaine hydrochloride~fentanyl citrate | Injection, solution | 2 mg/mL~6.28 microgram/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/03/2025 |
| ropivacaine hydrochloride~fentanyl citrate | Injection, solution | 2 mg/mL~6.28 microgram/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 28/03/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 28/03/2025 |
| gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 27/03/2025 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate | Injection, solution | 22.7 microgram/mL~21.3 mg/mL | Current | Limited Availability | Manufacturing | 27/03/2025 |
| sumatriptan succinate | Tablet, film coated | 140 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Limited Availability | Manufacturing | 27/03/2025 |
| clomipramine hydrochloride | Tablet, film coated | 25 mg | Current | Limited Availability | Manufacturing | 27/03/2025 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 27/03/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Unexpected increase in consumer demand | 27/03/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 27/03/2025 |
| entecavir | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| prilocaine hydrochloride~felypressin | Injection, solution | 30 mg/mL~.54 microgram/mL | Current | Unavailable | Manufacturing | 27/03/2025 |
| dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Current | Unavailable | Manufacturing | 27/03/2025 |
| emtricitabine~efavirenz~tenofovir disoproxil maleate | Tablet, film coated | 200 mg~600 mg~300 mg | Current | Limited Availability | Manufacturing | 27/03/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| naproxen | Tablet | 500 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 27/03/2025 |
| letrozole | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 26/03/2025 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 26/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Unavailable | Manufacturing | 26/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/03/2025 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 21.688 mg~13.88 mg | Current | Limited Availability | Manufacturing | 26/03/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 41.583 mg~10 mg | Anticipated | Available | Manufacturing | 26/03/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 10.396 mg~10 mg | Current | Unavailable | Manufacturing | 26/03/2025 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~20.791 mg | Resolved | Available | Manufacturing | 26/03/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/03/2025 |
| oxycodone hydrochloride | Capsule, hard | 10 mg | Current | Unavailable | Commercial Changes / Commercial viability | 26/03/2025 |
| oxycodone hydrochloride | Capsule, hard | 20 mg | Current | Unavailable | Commercial Changes / Commercial viability | 26/03/2025 |
| emtricitabine~tenofovir disoproxil fumarate | Tablet, film coated | 200 mg~300 mg | Resolved | Available | Manufacturing | 26/03/2025 |
| Pegfilgrastim | Injection, solution | 6 mg | Anticipated | Available | Manufacturing | 26/03/2025 |
| emtricitabine~tenofovir disoproxil fumarate | Tablet, film coated | 200 mg~300 mg | Current | Limited Availability | Manufacturing | 26/03/2025 |
| melatonin | Oral Liquid, solution | 1 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 26/03/2025 |
| gentamicin sulfate | Injection, solution | 135.6 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/03/2025 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~500 microgram | Current | Unavailable | Unexpected increase in consumer demand | 26/03/2025 |
| iopromide | Injection, solution | 498.72 mg/mL | Current | Unavailable | Manufacturing | 26/03/2025 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 26/03/2025 |
| zoledronic acid | Injection, concentrated | 4 mg | Resolved | Available | Commercial Changes / Commercial viability | 26/03/2025 |
| nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 26/03/2025 |
| isosorbide dinitrate | Tablet, uncoated | 5 mg | Anticipated | Available | Manufacturing | 25/03/2025 |
| trihexyphenidyl (benzhexol) hydrochloride | Tablet, uncoated | 5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 25/03/2025 |
| venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 25/03/2025 |
| venlafaxine hydrochloride | Capsule, modified release | 84.86 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 25/03/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Anticipated | Available | Manufacturing | 25/03/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Anticipated | Available | Manufacturing | 25/03/2025 |
| ondansetron | Tablet, orally disintegrating | 8 mg | Current | Limited Availability | Manufacturing | 25/03/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Anticipated | Available | Unexpected increase in consumer demand | 25/03/2025 |
| ketorolac trometamol | Injection, solution | 30 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 25/03/2025 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Limited Availability | Manufacturing | 25/03/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 25/03/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 25/03/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Anticipated | Available | Manufacturing | 25/03/2025 |
| olanzapine | Tablet, uncoated | 5 mg | Current | Unavailable | Manufacturing | 25/03/2025 |
| thiotepa | Injection, powder for | 15 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/03/2025 |
| thiotepa | Injection, powder for | 100 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/03/2025 |
| thiotepa | Injection, powder for | 400 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/03/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Unavailable | Manufacturing | 25/03/2025 |
| lorazepam | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 25/03/2025 |
| cisatracurium besilate | Injection, solution | 13.4 mg | Resolved | Available | Manufacturing | 25/03/2025 |
| spironolactone | Tablet, film coated | 100 mg | Anticipated | Available | Manufacturing | 25/03/2025 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Current | Unavailable | Manufacturing | 24/03/2025 |
| metoprolol succinate | Tablet, modified release | 47.5 mg | Resolved | Available | Manufacturing | 24/03/2025 |
| metoprolol succinate | Tablet, modified release | 190 mg | Resolved | Available | Manufacturing | 24/03/2025 |
| metoprolol succinate | Tablet, modified release | 95 mg | Resolved | Available | Manufacturing | 24/03/2025 |
| trandolapril | Capsule, hard | 1 mg | Current | Unavailable | Manufacturing | 24/03/2025 |
| trandolapril | Capsule, hard | 4 mg | Current | Unavailable | Manufacturing | 24/03/2025 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Anticipated | Available | Unexpected increase in consumer demand | 24/03/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Anticipated | Available | Unexpected increase in consumer demand | 24/03/2025 |
| methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 24/03/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Resolved | Available | Manufacturing | 24/03/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 24/03/2025 |
| deferasirox | Tablet, film coated | 90 mg | Anticipated | Available | Manufacturing | 24/03/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.688 mg | Current | Limited Availability | Manufacturing | 24/03/2025 |
| ethanol absolute~carmustine | Diluent, not applicable~Injection, powder for | 3 mL~100 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 24/03/2025 |
| deferasirox | Tablet, film coated | 360 mg | Current | Unavailable | Manufacturing | 24/03/2025 |
| metoclopramide hydrochloride monohydrate | Injection, solution | 10.54 mg | Anticipated | Available | Unexpected increase in consumer demand | 24/03/2025 |
| permethrin | Cream | 50 mg/g | Current | Limited Availability | Commercial Changes / Commercial viability | 24/03/2025 |
| dydrogesterone~estradiol | Tablet, film coated | 10 mg~2 mg | Current | Unavailable | Manufacturing | 24/03/2025 |
